Obagi Therapeutic Lotion Review

Look the lotion up on DailyMed, the federal drug-label database, and the first line is a small deflation: benzoyl peroxide 5%, OTC monograph acne drug, the same category as the tube next to the toothpaste at the pharmacy. Obagi's CLENZIderm M.D. Therapeutic Lotion is not prescription-strength and does not contain a prescription active. What it contains is a particular way of delivering an old molecule, and the case for paying $95 rather than $9 rests entirely on whether that way is worth it.

The molecule itself needs no defence. Benzoyl peroxide has been the first-line topical for inflammatory acne for half a century because it releases oxygen inside the follicle, kills the anaerobic bacteria that drive inflammation, does not breed resistance and loosens the keratin plugs that start comedones. The question that has been settled for almost as long is dose: in three double-blind studies across 153 patients, a 2.5% preparation reduced inflammatory lesions as effectively as 5% and 10%, with less peeling and burning than the 10%, and it cut the bacterial population and the free fatty acids in surface lipids within two weeks. Five percent, where this lotion sits, is a reasonable middle; it is not a stronger treatment than 2.5%, only a somewhat more irritating one.

Obagi's argument is about form rather than dose. Ordinary benzoyl peroxide gels are suspensions of crystals, which is why they feel gritty, sit unevenly in pores and leave white residue. The CLENZIderm system, launched in the late 2000s, was built around dissolving the benzoyl peroxide instead: dimethyl isosorbide, a penetration-enhancing glycol ether, and a pair of light solvent-emollients, dicaprylyl ether and benzyl benzoate, hold the active in solution in a water-and-propylene-glycol base so it reaches the follicle as a liquid. Squalane, the one emollient in an eleven-ingredient list, keeps the whole thing from stripping. There is no fragrance, no alcohol, no silicone and nothing decorative; it is a delivery vehicle and a drug.

On the skin the difference is real and easy to feel. The lotion is thin and cool, spreads in a sheer layer with none of the grit of a 5% gel, and dries in a minute to a matte, faintly powdery finish that moisturizer and sunscreen sit on without pilling. The adjustment period is the usual benzoyl peroxide one, just softened: some tightness by day three or four, a little flaking around the nose and mouth, a warm flush on sensitive skin, and then, by the second week, inflamed spots that are visibly shrinking and fewer new ones arriving. Obagi's once-daily start is sensible and its up-to-three-times-daily ceiling is generous; most oily skin does well at once or twice. Fifteen years of physician-office sales and several hundred reviews say the same thing: it works like benzoyl peroxide, it feels better than most benzoyl peroxide, and it costs a great deal more than benzoyl peroxide.

The limitations are the molecule's and the price's. It bleaches everything it dries on, so white pillowcases and washed hands are not optional. It cannot go on in the same application as tretinoin, retinol or an acid without multiplying irritation, and for a Nu-Derm patient that means a morning-and-night split a dermatologist will need to manage. Dry and sensitive skin will find even the softened 5% too much, and the DailyMed label says so plainly. Benzyl benzoate is a declared fragrance allergen for a small sensitised group, and propylene glycol high in the list irritates a few. None of that is unusual for the category.

Two details in use are worth passing on. Because the benzoyl peroxide is in solution, the lotion spreads much further than a gel, and the common mistake is applying too much; a pea-sized amount covers a cheek, and using more only speeds the dryness without adding effect. And the dimethyl isosorbide that dissolves the active is also a penetration enhancer for whatever goes on next, which is one more reason to keep a retinoid or an acid out of the same step and to give the lotion a full minute to dry before the moisturizer.

The price is. Ninety-five dollars for 47 ml is roughly ten times what a drugstore 5% benzoyl peroxide costs, and used once daily over the face the tube lasts six to eight weeks; at three times a day it can be gone in a month. What the money buys is the solubilised vehicle, the squalane, the absence of grit and residue, the physician-brand channel and the reassurance of a product that was designed as one part of a coherent three-step system. What it does not buy is a stronger drug, a faster result or any published head-to-head evidence that solubilised benzoyl peroxide clears acne better than the crystalline kind; Obagi's penetration data are the brand's own.

For whom, then? A CLENZIderm system patient who has been told to use it and has skin that has tolerated it, or an oily-skinned adult who has tried the drugstore gels, hated the grit and the residue, and is willing to pay for a benzoyl peroxide that feels like skincare. For those people it is a well-made product and a comfortable one. For anyone starting benzoyl peroxide for the first time, a 2.5% drugstore gel is the evidence-based first move, and the $86 difference will buy a good moisturizer, a sunscreen and most of a dermatologist's visit.